Fat(al) attraction: Picornaviruses Usurp Lipid Transfer at Membrane Contact Sites to Create Replication Organelles

Trends in Microbiology

Volumn 24, Issue 7, 2016, Pages 535-546

  van der Schaar, Hilde M ^a   Dorobantu, Cristina M ^a   Albulescu, Lucian ^a   Strating, Jeroen R P M ^a   van Kuppeveld, Frank J M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

cholesterol; lipid; membrane contact site; phosphatidylinositol 4 phosphate; picornavirus; replication organelle

Indexed keywords

FAT; GUANINE NUCLEOTIDE EXCHANGE FACTOR; LIPID; PHOSPHATIDYLINOSITOL 4 PHOSPHATE; PHOSPHATIDYLINOSITOL KINASE; PROTEIN ACBD3; PROTEIN C10ORF76; PROTEIN GBF1; PROTEIN PI4KB; REACTIVE OXYGEN METABOLITE; SINGLE STRANDED RNA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

CELL MEMBRANE TRANSPORT; CELL ORGANELLE; ENDOCYTOSIS; ENTEROVIRUS; LIFE CYCLE; LIPID HOMEOSTASIS; LIPID TRANSPORT; MOLECULAR MECHANICS; NONHUMAN; PICORNAVIRIDAE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; RNA VIRUS; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS REPLICATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; INTRACELLULAR MEMBRANE; LIPID METABOLISM; METABOLISM; PATHOGENICITY; PHYSIOLOGY; VIROLOGY;

ENTEROVIRUS; GENOME, VIRAL; HUMANS; INTRACELLULAR MEMBRANES; LIPID METABOLISM; LIPIDS; VIRUS REPLICATION;

EID: 84962164860     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2016.02.017     Document Type: Review

References (90)

1. 1 Tapparel, C., et al. Picornavirus and enterovirus diversity with associated human diseases. Infect. Genet. Evol. 14 (2013), 282–293.
2. 2 Ooi, M.H., et al. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 9 (2010), 1097–1105.
3. 3 Gern, J.E., The ABCs of rhinoviruses, wheezing, and asthma. J. Virol. 84 (2010), 7418–7426.
4. 4 Midgley, C.M., et al. Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): A descriptive epidemiological investigation. Lancet Respir. Med. 3 (2015), 879–887.
5. 5 Hamborsky, J., et al. Poliomyelitis. Hamborsky, J., et al. (eds.) Centers for Disease Controle and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases, 13th edn, 2015, Public Health Foundation, 297–310.
6. 6 Sin, J., et al. Recent progress in understanding coxsackievirus replication, dissemination, and pathogenesis. Virology 484 (2015), 288–304.
7. 7 Tuthill, T.J., et al. Picornaviruses. Curr. Top. Microbiol. Immunol. 343 (2010), 43–89.
8. 8 Bird, S.W., et al. Nonlytic viral spread enhanced by autophagy components. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), 13081–13086.
9. 9 Jackson, W.T., et al. Subversion of cellular autophagosomal machinery by RNA viruses. PLoS Biol., 3, 2005, e156.
10. 10 Kirkegaard, K., Jackson, W.T., Topology of double-membraned vesicles and the opportunity for non-lytic release of cytoplasm. Autophagy 1 (2005), 182–184.
11. 11 Chen, Y.H., et al. Phosphatidylserine vesicles enable efficient en bloc transmission of enteroviruses. Cell 160 (2015), 619–630.
12. 12 Robinson, S.M., et al. Coxsackievirus B exits the host cell in shed microvesicles displaying autophagosomal markers. PLoS Pathog., 10, 2014, e1004045.
13. 13 Feng, Z., et al. A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature 496 (2013), 367–371.
14. 14 Romero-Brey, I., et al. Three-dimensional architecture and biogenesis of membrane structures associated with hepatitis C virus replication. PLoS Pathog., 8, 2012, e1003056.
15. 15 den Boon, J.A., Ahlquist, P., Organelle-like membrane compartmentalization of positive-strand RNA virus replication factories. Annu. Rev. Microbiol. 64 (2010), 241–256.
16. 16 Miller, S., Krijnse-Locker, J., Modification of intracellular membrane structures for virus replication. Nat. Rev. Microbiol. 6 (2008), 363–374.
17. 17 Bienz, K., et al. Kinetics and location of poliovirus macromolecular synthesis in correlation to virus-induced cytopathology. Virology 100 (1980), 390–399.
18. 18 Kallman, F., et al. Fine structure of changes produced in cultured cells sampled at specified intervals during a single growth cycle of polio virus. J. Biophys. Biochem. Cytol. 4 (1958), 301–308.
19. 19 Limpens, R.W.A.L., et al. The transformation of enterovirus replication structures: A three-dimensional study of single- and double-membrane compartments. MBio, 2, 2011 e00166-11.
20. 20 Belov, G.A., et al. Complex dynamic development of poliovirus membranous replication complexes. J. Virol. 86 (2012), 302–312.
21. 21 Gazina, E.V., et al. Differential requirements for COPI coats in formation of replication complexes among three genera of Picornaviridae. J. Virol. 76 (2002), 11113–11122.
22. 22 Belov, G.A., et al. Hijacking components of the cellular secretory pathway for replication of poliovirus RNA. J. Virol. 81 (2007), 558–567.
23. 23 Hsu, N-Y., et al. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell 141 (2010), 799–811.
24. 24 Wong, J., et al. Autophagosome supports coxsackievirus B3 replication in host cells. J. Virol. 82 (2008), 9143–9153.
25. 25 Kemball, C.C., et al. Coxsackievirus infection induces autophagy-like vesicles and megaphagosomes in pancreatic acinar cells in vivo. J. Virol. 84 (2010), 12110–12124.
26. 26 Alirezaei, M., et al. Coxsackievirus can exploit LC3 in both autophagy-dependent and -independent manners in vivo. Autophagy 11 (2015), 1389–1407.
27. 27 Belov, G.A., van Kuppeveld, F.J., (+)RNA viruses rewire cellular pathways to build replication organelles. Curr. Opin. Virol. 2 (2012), 740–747.
28. 28 Janmey, P.A., Kinnunen, P.K., Biophysical properties of lipids and dynamic membranes. Trends Cell Biol. 16 (2006), 538–546.
29. 29 van Meer, G., et al. Membrane lipids: Where they are and how they behave. Nat. Rev. Mol. Cell Biol. 9 (2008), 112–124.
30. 30 Bigay, J., Antonny, B., Curvature, lipid packing, and electrostatics of membrane organelles: Defining cellular territories in determining specificity. Dev. Cell 23 (2012), 886–895.
31. 31 Holthuis, J.C., Menon, A.K., Lipid landscapes and pipelines in membrane homeostasis. Nature 510 (2014), 48–57.
32. 32 De Matteis, M.A., Rega, L.R., Endoplasmic reticulum-Golgi complex membrane contact sites. Curr. Opin. Cell Biol. 35 (2015), 43–50.
33. 33 Balla, T., Phosphoinositides: Tiny lipids with giant impact on cell regulation. Physiol. Rev. 93 (2013), 1019–1137.
34. 34 Wong, K., et al. Subcellular locations of phosphatidylinositol 4-kinase isoforms. J. Biol. Chem. 272 (1997), 13236–13241.
35. 2 on the Golgi complex. Nat. Cell Biol. 1 (1999), 280–287.
36. 36 van der Schaar, H.M., et al. A novel, broad-spectrum inhibitor of enterovirus replication that targets host cell factor phosphatidylinositol 4-kinase IIIbeta. Antimicrob. Agents Chemother. 57 (2013), 4971–4981.
37. 37 Dorobantu, C.M., et al. Recruitment of PI4KIIIbeta to coxsackievirus B3 replication organelles is independent of ACBD3, GBF1, and Arf1. J. Virol. 88 (2014), 2725–2736.
38. 38 Dorobantu, C.M., et al. GBF1- and ACBD3-independent recruitment of PI4KIIIbeta to replication sites by rhinovirus 3A proteins. J. Virol. 89 (2015), 1913–1918.
39. 39 Greninger, A.L., et al. The 3A protein from multiple picornaviruses utilizes the Golgi adaptor protein ACBD3 to recruit PI4KIIIβ. J. Virol. 86 (2012), 3605–3616.
40. 40 Arita, M., Phosphatidylinositol-4 kinase III beta and oxysterol-binding protein accumulate unesterified cholesterol on poliovirus-induced membrane structure. Microbiol. Immunol. 58 (2014), 239–256.
41. 41 Wessels, E., et al. A viral protein that blocks Arf1-mediated COP-I assembly by inhibiting the guanine nucleotide exchange factor GBF1. Dev. Cell 11 (2006), 191–201.
42. 42 Lanke, K.H., et al. GBF1, a guanine nucleotide exchange factor for Arf, is crucial for coxsackievirus B3 RNA replication. J. Virol. 83 (2009), 11940–11949.
43. 43 Belov, G.A., et al. A critical role of a cellular membrane traffic protein in poliovirus RNA replication. PLoS Pathog., 4, 2008, e1000216.
44. 44 D'Souza-Schorey, C., Chavrier, P., ARF proteins: Roles in membrane traffic and beyond. Nat. Rev. Mol. Cell Biol. 7 (2006), 347–358.
45. 45 Donaldson, J.G., et al. Multiple activities for Arf1 at the Golgi complex. Biochim. Biophys. Acta 1744 (2005), 364–373.
46. 46 Cuconati, A., et al. Brefeldin A inhibits cell-free, de novo synthesis of poliovirus. J. Virol. 72 (1998), 6456–6464.
47. 47 Beck, R., et al. The COPI system: Molecular mechanisms and function. FEBS Lett. 583 (2009), 2701–2709.
48. 48 Belov, G.A., et al. Poliovirus replication requires the N-terminus but not the catalytic Sec7 domain of ArfGEF GBF1. Cell. Microbiol. 12 (2010), 1463–1479.
49. 49 Verheije, M.H., et al. Mouse hepatitis coronavirus RNA replication depends on GBF1-mediated ARF1 activation. PLoS Pathog., 4, 2008, e1000088.
50. 50 Zhang, L., et al. ARF1 and GBF1 generate a PI4P-enriched environment supportive of Hepatitis C virus replication. PLoS ONE, 7, 2012, e32135.
51. 51 Sasaki, J., et al. ACBD3-mediated recruitment of PI4KB to picornavirus RNA replication sites. EMBO J. 31 (2012), 754–766.
52. 52 Teoule, F., et al. The Golgi protein ACBD3, an interactor for poliovirus protein 3A, modulates poliovirus replication. J. Virol. 87 (2013), 11031–11046.
53. 53 Jovic, M., et al. Two phosphatidylinositol 4-kinases control lysosomal delivery of the Gaucher disease enzyme, beta-glucocerebrosidase. Mol. Biol. Cell 23 (2012), 1533–1545.
54. 54 Greninger, A.L., et al. ACBD3 interaction with TBC1 domain 22 protein is differentially affected by enteroviral and kobuviral 3A protein binding. MBio, 4, 2013 e00098-13.
55. 55 Blomen, V.A., et al. Gene essentiality and synthetic lethality in haploid human cells. Science 350 (2015), 1092–1096.
56. 56 Clayton, E.L., et al. Mammalian phosphatidylinositol 4-kinases as modulators of membrane trafficking and lipid signaling networks. Prog. Lipid Res. 52 (2013), 294–304.
57. 57 De Matteis, M.A., et al. Phosphatidylinositol-4-phosphate: The Golgi and beyond. Bioessays 35 (2013), 612–622.
58. 58 Mesmin, B., et al. A four-step cycle driven by PI(4)P hydrolysis directs sterol/PI(4)P exchange by the ER-Golgi tether OSBP. Cell 155 (2013), 830–843.
59. 59 Arita, M., et al. Oxysterol-binding protein family I is the target of minor enviroxime-like compounds. J. Virol. 87 (2013), 4252–4260.
60. 60 Roulin, P.S., et al. Rhinovirus uses a phosphatidylinositol 4-phosphate/cholesterol counter-current for the formation of replication compartments at the ER-Golgi interface. Cell Host Microbe 16 (2014), 677–690.
61. 61 Strating, J.R., et al. Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein. Cell Rep. 10 (2015), 600–615.
62. 62 Albulescu, L., et al. Broad-range inhibition of enterovirus replication by OSW-1, a natural compound targeting OSBP. Antivir. Res. 117 (2015), 110–114.
63. 63 Wang, H., et al. Oxysterol-binding protein is a phosphatidylinositol 4-kinase effector required for HCV replication membrane integrity and cholesterol trafficking. Gastroenterology 146 (2014), 1373–1385.
64. 64 Arita, M., et al. Phosphatidylinositol 4-kinase III beta is a target of enviroxime-like compounds for antipoliovirus activity. J. Virol. 85 (2011), 2364–2372.
65. 65 Ilnytska, O., et al. Enteroviruses harness the cellular endocytic machinery to remodel the host cell cholesterol landscape for effective viral replication. Cell Host Microbe 14 (2013), 281–293.
66. 66 Albulescu, L., et al. Cholesterol shuttling is important for RNA replication of coxsackievirus B3 and encephalomyocarditis virus. Cell. Microbiol. 17 (2015), 1144–1156.
67. 67 Wilfling, F., et al. Arf1/COPI machinery acts directly on lipid droplets and enables their connection to the ER for protein targeting. Elife, 3, 2014, e01607.
68. 68 Cornell, C.T., et al. Coxsackievirus B3 proteins directionally complement each other to downregulate surface Major Histocompatibility Complex class I. J. Virol. 81 (2007), 6785–6797.
69. 69 Ford Siltz, L.A., et al. New small molecule inhibitors effectively blocking picornavirus replication. J. Virol. 88 (2014), 11091–11107.
70. 70 Perry, R.J., Ridgway, N.D., Oxysterol-binding protein and vesicle-associated membrane protein-associated protein are required for sterol-dependent activation of the ceramide transport protein. Mol. Biol. Cell 17 (2006), 2604–2616.
71. 71 Raychaudhuri, S., Prinz, W.A., The diverse functions of oxysterol-binding proteins. Annu. Rev. Cell Dev. Biol. 26 (2010), 157–177.
72. 72 Olkkonen, V.M., Li, S., Oxysterol-binding proteins: Sterol and phosphoinositide sensors coordinating transport, signaling and metabolism. Prog. Lipid Res. 52 (2013), 529–538.
73. 73 Chung, J., et al. PI4P/phosphatidylserine countertransport at ORP5- and ORP8-mediated ER-plasma membrane contacts. Science 349 (2015), 428–432.
74. 74 Nchoutmboube, J.A., et al. Increased long chain acyl-CoA synthetase activity and fatty acid import is linked to membrane synthesis for development of picornavirus replication organelles. PLoS Pathog., 9, 2013, e1003401.
75. 75 Ishikawa-Sasaki, K., et al. A complex comprising phosphatidylinositol 4-kinase IIIbeta, ACBD3, and Aichi virus proteins enhances phosphatidylinositol 4-phosphate synthesis and is critical for formation of the viral replication complex. J. Virol. 88 (2014), 6586–6598.
76. 76 Van der Linden, L., et al. Differential effects of the putative GBF1 inhibitors Golgicide A and AG1478 on enterovirus replication. J. Virol. 84 (2010), 7535–7542.
77. 77 Irurzun, A., et al. Involvement of membrane traffic in the replication of poliovirus genomes: Effects of brefeldin A. Virology 191 (1992), 166–175.
78. 78 Dorobantu, C.M., et al. Modulation of the host lipid landscape to promote RNA virus replication: The picornavirus encephalomyocarditis virus converges on the pathway used by hepatitis C virus. PLoS Pathog., 11, 2015, e1005185.
79. 79 Reiss, S., et al. Recruitment and activation of a lipid kinase by Hepatitis C Virus NS5A is essential for integrity of the membranous replication compartment. Cell Host Microbe 9 (2011), 32–45.
80. 80 Rothwell, C., et al. Cholesterol biosynthesis modulation regulates dengue viral replication. Virology 389 (2009), 8–19.
81. 81 Mackenzie, J.M., et al. Cholesterol manipulation by West Nile Virus perturbs the cellular immune response. Cell Host Microbe 2 (2007), 229–239.
82. 82 Martín-Acebes, M.A., et al. West Nile Virus replication requires fatty acid synthesis but is independent on phosphatidylinositol-4-phosphate lipids. PLoS ONE, 6, 2011, e24970.
83. 83 Barajas, D., et al. Co-opted oxysterol-binding ORP and VAP proteins channel sterols to RNA virus replication sites via membrane contact sites. PLoS Pathog., 10, 2014, e1004388.
84. 84 Coyne, C.B., et al. Comparative RNAi screening reveals host factors involved in enterovirus infection of polarized endothelial monolayers. Cell Host Microbe 9 (2011), 70–82.
85. 85 Volle, R., et al. Differential permissivity of human cerebrovascular endothelial cells to enterovirus infection and specificities of serotype EV-A71 in crossing an in vitro model of the human blood-brain barrier. J. Gen. Virol. 96 (2015), 1682–1695.
86. 86 Alirezaei, M., et al. Pancreatic acinar cell-specific autophagy disruption reduces coxsackievirus replication and pathogenesis in vivo. Cell Host Microbe 11 (2012), 298–305.
87. 87 Thibaut, H.J., et al. Fitness and virulence of a coxsackievirus mutant that can circumnavigate the need for phosphatidylinositol 4-kinase class III beta. J. Virol. 88 (2014), 3048–3051.
88. 88 Chuang, C., et al. Inactivation of the host lipin gene accelerates RNA virus replication through viral exploitation of the expanded endoplasmic reticulum membrane. PLoS Pathog., 10, 2014, e1003944.
89. 89 Helle, S.C., et al. Organization and function of membrane contact sites. Biochim. Biophys. Acta 1833 (2013), 2526–2541.
90. 90 Fernandez-Busnadiego, R., et al. Three-dimensional architecture of extended synaptotagmin-mediated endoplasmic reticulum-plasma membrane contact sites. Proc. Natl. Acad. Sci. U.S.A. 112 (2015), E2004–E2013.